| 1. |
Takeda A, Hasegawa E, Nakao S, Ishikawa K, Murakami Y, Hisatomi T, Arima M, Yawata N, Oda Y, Kimura K, Yoshikawa H, Sonoda KH., Vitreous levels of interleukin-35 as a prognostic factor in B-cell vitreoretinal lymphoma, Scientific Reports, 10.1038/s41598-020-72962-z , 10, 1, 15715, 2020.09. |
| 2. |
Ito T, Takeda A, Fujiwara K, Hasegawa E, Nakao S, Ohishi Y, Oda Y, Yoshikawa H, Sonoda KH., Risk factors for failure of vitrectomy cell block technique in cytological diagnosis of vitreoretinal lymphoma., Graefe’s Arch Clin Exp Opthalmol., 257, 5, 1029-1036, 2019.05. |
| 3. |
Takeda A, Yamada H, Hasegawa E, Arima M, Notomi N, Myojin S, Yoshimura T, Hisatomi T, Enaida H, Yanai R, Kimura K, Ishibashi T, Sonoda KH., Crucial role of P2X7 receptor for effector T cell activation in experimental autoimmune uveitis., Jpn J Ophthalmol., 62, 3, 398-406, 2018.05. |
| 4. |
Sato K, Takeda A, Hasegawa E, Jo YJ, Arima M, Oshima Y, Yanai R, Nakazawa T, Yuzawa M, Nakashizuka H, Shimada H, Kimura K, Ishibashi T, Sonoda KH., Interleukin-6 plays a crucial role in the development of subretinal fibrosis in a mouse model., Immunological Medicine, 41, 1, 23-29, 2018.01. |
| 5. |
Taki R, Takeda A, Yoshikawa H, Fukuhara T, Arita R, Suehiro Y, Che I, Kumano Y, Nakamura T, Ishibashi T, Clinical features of systemic metastatic retinal lymphoma in Japanese patients., Ocul Immunol Inflamm., 25, 5, 654-662, 2017.10. |
| 6. |
Takeda A, Yoshikawa H, Fukuhara T, Hikita S, Otomo T, Arita R, Oshima Y, Hisatomi T, Kimura K, Yoshida S, Kawano Y, Sonoda KH, Ishibashi T, Distinct profiles of soluble cytokine receptors between B-cell vitreoretinal lymphoma and uveitis, Invest Ophthalmol Vis Sci., 56, 12, 7516-7523, 2015.12. |
| 7. |
Takeda A, Hasegawa E, Fukuhara T, Hirakawa S, Yamada H, Yang Y, Yoshimura T, Hisatomi T, Oshima Y, Yoshida H, Sonoda KH, Ishibashi T, EBI3 is pivotal for the initiation of experimental autoimmune uveitis., Experimental Eye Research, doi: 10.1016/j.exer.2014.06.004., 125, 107-113, 2014.08. |
| 8. |
Yang Y, Takeda A, Yoshimura T, Oshima Y, Sonoda KH, Ishibashi T, IL-10 is significantly involved in HSP70-regulation of experimental subretinal fibrosis, Plos one, 8, 12, e80288, 2013.12. |
| 9. |
Hasegawa E, Oshima Y, Takeda A, Saeki K, Yoshida H, Sonoda KH, Ishibashi T., IL-27 inhibits pathological ocular neovascularization due to laser burn., J Leukoc Biol, 22045869, 91, 2, 267-273, 2012.02. |
| 10. |
Takeda A, Baffi JZ, Kleinman ME, Cho W, Nozaki M, Yamada K, Kaneko H, Albuquerque RJC, Dridi S, Saito K, Raisler BJ, Budd SJ, Geisen P, Munitz A, Ambati BK, Rich MG, Ishibashi T, Wright JD, Humbles AA, Gerard CJ, Ogura Y, Pan Y, Smith JR, Grisanti S, Hartnett ME, Rothenberg ME, Ambati J., CCR3 is a therapeutic and diagnostic non-inflammatory target for neovascular age-related macular degeneration, Nature, 460, 7252, 225-230, 2009.07. |
| 11. |
Kleinman ME*, Yamada K*, Takeda A*, Chandrasekaren V, Nozaki M, Baffi JZ, Albuquerque RJC, Yamasaki S, Itaya M, Pan Y, Appukutan B, Gibbs D, Yang Z, Kariko K, Ambati BK, Wilgus TA, DiPietro LA, Sakurai E, Zhang K, Smith JR, Taylor EW, Ambati J., Sequence- and target-independent suppression of angiogenesis by siRNA via TLR3, Nature, 452, 7187, 591-597, 2008.03. |
| 12. |
Ambati BK, Nozaki M*, Singh N*, Takeda A*, Jani PD*, Suthar T, Albuquerque RJC, Richter E, Sakurai E, Newcomb MT, Kleinman ME, Caldwell RB, Lin Q, Ogura Y, Orecchia A, Samuelson DA, Agnew DW, Leger JS, Green WR, Mahasreshti PJ, Curiel DT, Kwan D, Marsh H, Ikeda S, Leiper LJ, Collinson JM, Bogdanovich S, Khurana TS, Shibuya M, Baldwin ME, Ferrara N, Gerber HP, De Falco S, Witta J*, Baffi JZ*, Raisler BJ*, Ambati J., Corneal avascularity is due to soluble VEGF receptor-1, Nature, 443, 7114, 993-997, 2006.10. |
| 13. |
Yoshimura T, Takeda A, Hamano S, Miyazaki Y, Kinjyo I, Ishibashi T, Yoshimura A, Yoshida H, Two-sided roles of IL-27; induction of Th1 differentiation on naïve CD4+ T cells vs. suppression of pro-inflammatory cytokine production including IL-23-induced IL-17 on activated CD4+ T cells partially through STAT3-dependent mechanism., J Immunol , 177, 8, 5377-5385, 2006.08. |
| 14. |
Takeda A, Hamano S, Shiraishi H, Yoshimura T, Ogata H, Ishii K, Ishibashi T, Yoshimura A, Yoshida H., Hyperproliferation and hyperproduction of cytokines by WSX-1-overexpressing CD4+ T cells in response to TCR stimulation, Int Immunol, 17, 7, 889-897, 2005.07. |
| 15. |
Takeda A, Hamano S, Yamanaka A, Hanada T, Ishibashi T, Mak TW, Yoshimura A, Yoshida H., Role of IL-27/WSX-1 signaling for induction of T-bet through activation of STAT1 during initial Th1 commitment., J Immunol, 170, 10, 4886-4890, 2003.05. |
| 16. |
Takeda A, Hata Y, Shiose S, Sassa Y, Honda M, Fujisawa K, Sakamoto T, Ishibashi T., Suppression of experimental choroidal neovascularization utilizing KDR selective receptor tyrosine kinase inhibitor, Graefe’s Arch Clin Exp Opthalmol, 10.1007/s00417-003-0688-7, 241, 9, 765-772, 2003.09. |
